The New York Times reported Monday night that President Trump has a “small personal financial interest” in Sanofi, a French drugmaker that produces a brand-name version of hydroxychloroquine, a medication touted by Trump as a coronavirus treatment—of which the effectiveness has not been proven.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,